Pure red cell aplasia: Clinical features and treatment results in 16 cases
article
OA: closed
CC0
Abstract
Pure red cell aplasia (PRCA) is a rare hematological disease characterized by selective marrow erythroid aplasia. We report the clinical features and treatment results of 16 Chinese patients with PRCA. Nine (56%) cases were not associated with any underlying disorders and were considered idiopathic, while seven patients (44%) had associated diseases, three involving the thymus, two with T large granular lymphocyte leukemia (T-LGLL), and one each with Stevens-Johnson syndrome and acute hepatitis A. Conventional-dose corticosteroid therapy resulted in complete remission in three of 13 patients. Cyclosporin A was used in six patients. There were three complete and one partial remissions. High-dose methylprednisolone was ineffective in four patients who failed conventional-dose corticosteroids but achieved complete remission in one patient with thymoma who did not respond to thymectomy. Antithymocyte globulin was used in four patients, resulting in partial remission in only one patient with concomitant T-LGLL. Intravenous gamma globulin and danazol were ineffective in three patients. Thymectomy was performed in two patients, with one patient remitting. This is the largest series of PRCA reported in an oriental population. Our results indicate that treatment of PRCA may still be problematic and better therapeutic strategy will have to be defined.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (29)
- doi:10.1007/bf02076698 via openalex
- doi:10.1097/00005792-196705000-00001 via openalex
- doi:10.1007/978-1-4612-3254-4_16 via openalex
- doi:10.1002/ajh.2830230408 via openalex
- doi:10.1093/ajcp/103.3.346 via openalex
- doi:10.1093/ajcp/103.1.76 via openalex
- doi:10.1172/jci111195 via openalex
- doi:10.1097/00005792-198609000-00006 via openalex
- doi:10.7326/0003-4819-100-2-202 via openalex
- doi:10.1002/ajh.2830240312 via openalex
- doi:10.1182/blood.v52.1.255.255 via openalex
- doi:10.1002/ajh.2830240308 via openalex
- doi:10.1002/ajh.2830170412 via openalex
- doi:10.1016/0002-9343(73)90195-2 via openalex
- doi:10.1111/j.1600-0609.1988.tb01183.x via openalex
- doi:10.1159/000205292 via openalex
- doi:10.1172/jci110713 via openalex
- W153695106 via openalex
- doi:10.1056/nejm198710153171606 via openalex
- doi:10.1182/blood.v57.6.1025.1025 via openalex
- doi:10.1182/blood.v45.2.247.247 via openalex
- doi:10.1182/blood.v71.4.923.bloodjournal714923 via openalex
- doi:10.1073/pnas.58.2.493 via openalex
- W2405259604 via openalex
- W2415885139 via openalex
- W2416761194 via openalex
- doi:10.1002/ajh.2830200212 via openalex
- doi:10.1097/00007611-199311000-00021 via openalex
- doi:10.1002/1097-0142(196502)18:2<216::aid-cncr2820180214>3.0.co;2-6 via openalex
Source provenance
- openalex
- last seen: 2026-05-11T06:42:59.773506+00:00
License: CC0
· commercial use OK